Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A
Maria Francesca Testa, Mirko Pinotti, Alessio Branchini, Maria Elisa Mancuso, Francesco Bernardi, Dario Balestra · 2026
Read Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A by Maria Francesca Testa, Mirko Pinotti, Alessio Branchini, Maria Elisa Mancuso, Francesco Bernardi, Dario Balestra (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13576119.txt.
Description
Maria Francesca Testa leads a 2026 study of why some haemophilia A gene faults carry more risk of treatment-blocking antibodies than others. In this bleeding disorder, patients replace the missing factor VIII protein, yet some develop inhibitors that blunt the therapy. Nonsense mutations, which stop the protein early, vary widely in that risk.
The team studied 335 such mutations in a European database covering 1,048 patients. They focused on readthrough, a process where the cell sometimes skips the stop signal and makes traces of full protein. Mutations allowing normal readthrough were less tied to inhibitors, while those with none clustered in high-risk cases. Lab expression tests and immune binding calculations supported the pattern. The authors propose a new genetic grouping to sharpen risk estimates for families and clinicians.
Catalog record
| CREATOR | Maria Francesca Testa, Mirko Pinotti, Alessio Branchini, Maria Elisa Mancuso, Francesco Bernardi, Dario Balestra |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52263 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |